Research Article
Reduction of Hepatitis B Surface Antigen May Be More Significant in PEGylated Interferon-Alpha Therapy Combined with Nucleotide Analogues than Combined with Nucleoside Analogues in Chronic Hepatitis B Patients: A Propensity Score Matching Study
Figure 3
The rate of different indicators at the end of therapy. (a) Efficacy index before propensity score matching; (b) efficacy index after propensity score matching. .
(a) |
(b) |